The abstract is read at the publisher; the summary is JClub's.
Microbiota-driven C-C motif chemokine ligand 25–C-C motif chemokine receptor 9 signaling in the distal small intestine is linked to obesity-associated metabolic dysfunction, with CCL25 levels dropping after bariatric surgery.
- Why it matters: It remains unclear how region-specific intestinal immune organization shapes systemic metabolic outcomes in metabolically unhealthy obesity.
- What they did: The study combined human serum chemokine profiling (before vs after bariatric surgery) with diet-induced obese male mice using microbiota manipulation, single-cell RNA sequencing, and genetic or pharmacologic C-C motif chemokine receptor 9 perturbation, plus parabiosis and adoptive transfer.
- The result: In obese mice, epithelial CCL25 induced C-C motif chemokine receptor 9–dependent ileal type 2 innate lymphoid cell accumulation and inflammatory reprogramming; disrupting the axis reversed intestinal remodeling, preserved barrier integrity, and improved glucose homeostasis without changing body weight, while redirecting circulating type 2 innate lymphoid cells from small intestine to peripheral tissues.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.